High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Titel:
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Auteur:
Dorman, Susan E. Nahid, Payam Kurbatova, Ekaterina V. Goldberg, Stefan V. Bozeman, Lorna Burman, William J. Chang, Kwok-Chiu Chen, Michael Cotton, Mark Dooley, Kelly E. Engle, Melissa Feng, Pei-Jean Fletcher, Courtney V. Ha, Phan Heilig, Charles M. Johnson, John L. Lessem, Erica Metchock, Beverly Miro, Jose M. Nhung, Nguyen Viet Pettit, April C. Phillips, Patrick P.J. Podany, Anthony T. Purfield, Anne E. Robergeau, Kathleen Samaneka, Wadzanai Scott, Nigel A. Sizemore, Erin Vernon, Andrew Weiner, Marc Swindells, Susan Chaisson, Richard E.